Robert Wieder, MD, PhD is a Medical Oncologist with experience in clinical investigations in cancer and in expanding NCI-supported clinical trial opportunities to underserved communities. Dr. Wieder is also a basic science investigator in the fields of breast cancer dormancy in the bone marrow and the roles of retinoids and deltanoids in potentiating the effects of breast cancer therapy. He is a Professor of Medicine at the New Jersey Medical School and served as Provost of Rutgers Biomedical and Health Sciences-Newark.